| Kathleen Forti-gallant, FNP | |
|
925 Union St Ste 3, Bangor, ME 04401-3051 | |
| (207) 973-9980 | |
| (207) 973-7515 |
| Full Name | Kathleen Forti-gallant |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 26 Years |
| Location | 925 Union St Ste 3, Bangor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407876279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | CNP81358 (Maine) | Primary |
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | R028705 (Maine) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern Maine Medical Center | Bangor, ME | Hospital |
| Sebasticook Valley Health | Pittsfield, ME | Hospital |
| Northern Light Inland Hospital | Waterville, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acadia Hospital Corp. | 7719878495 | 80 |
| Eastern Maine Medical Center | 2062315161 | 577 |
News Archive
Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.
Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.
Contrary to the psychoanalytic theory that children who appear to be well adjusted as adolescents are actually "ticking time bombs," most normal teenagers adapt to and benefit from life experiences, a Northwestern University study has found.
Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm's marine natural products library derived from its extensive collection of marine micro-organisms.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 7 days ago
| Entity Name | Eastern Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790789147 PECOS PAC ID: 2062315161 Enrollment ID: O20040128000088 |
News Archive
Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.
Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.
Contrary to the psychoanalytic theory that children who appear to be well adjusted as adolescents are actually "ticking time bombs," most normal teenagers adapt to and benefit from life experiences, a Northwestern University study has found.
Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm's marine natural products library derived from its extensive collection of marine micro-organisms.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 7 days ago
| Entity Name | Acadia Hospital Corp. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215940523 PECOS PAC ID: 7719878495 Enrollment ID: O20040323000136 |
News Archive
Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.
Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.
Contrary to the psychoanalytic theory that children who appear to be well adjusted as adolescents are actually "ticking time bombs," most normal teenagers adapt to and benefit from life experiences, a Northwestern University study has found.
Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm's marine natural products library derived from its extensive collection of marine micro-organisms.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 7 days ago
| Entity Name | Sebasticook Valley Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457461477 PECOS PAC ID: 3476462797 Enrollment ID: O20040513001197 |
News Archive
Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.
Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.
Contrary to the psychoanalytic theory that children who appear to be well adjusted as adolescents are actually "ticking time bombs," most normal teenagers adapt to and benefit from life experiences, a Northwestern University study has found.
Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm's marine natural products library derived from its extensive collection of marine micro-organisms.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Forti-gallant, FNP 43 Whiting Hill Rd Ste 300, Brewer, ME 04412-1006 Ph: (207) 973-5035 | Kathleen Forti-gallant, FNP 925 Union St Ste 3, Bangor, ME 04401-3051 Ph: (207) 973-9980 |
News Archive
Australian sufferers of chronic obstructive pulmonary disorder (COPD), one of the most important causes of breathlessness and difficulty performing tasks of normal daily life, have the opportunity to participate in a worldwide study, starting this month, assessing a potential new treatment.
Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.
Contrary to the psychoanalytic theory that children who appear to be well adjusted as adolescents are actually "ticking time bombs," most normal teenagers adapt to and benefit from life experiences, a Northwestern University study has found.
Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm's marine natural products library derived from its extensive collection of marine micro-organisms.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 7 days ago
Jennie S. Dubosky, MS, A.P.R.N.,CNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1068 Union St, Bangor, ME 04401 Phone: 207-947-0147 Fax: 207-990-3365 | |
Pamela S Miller, PMH NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp, Bangor, ME 04401 Phone: 207-973-6100 Fax: 207-973-6109 | |
Bridget Larson, APRN CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp, Bangor, ME 04401 Phone: 207-973-6100 Fax: 207-973-6109 | |
Elizabeth R Pelissier, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-945-5247 Fax: 207-990-1248 | |
Deidre P Tukey, MSN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-945-5247 Fax: 207-990-1248 |